STUDY ON THE EFFECTIVENESS OF METABOLIC MEDICINES FOR CANCER

• Research type

  Research Study

• Full title

  A NON RANDOMISED, NON BLINDED REAL WORLD STUDY OF THE SAFETY, TOLERABILITY AND EFFECTIVENESS OF METABOLIC MEDICINES FOR THE TREATMENT OF CANCER COMPARED AGAINST HISTORICAL CONTROLS

• IRAS ID

  219706

• Contact name

  Robin Bannister

• Contact email

  robin.bannister@seekacure.com

• Sponsor organisation

  Health Clinics Limited

• Eudract number

  2016-001830-91

• Clinicaltrials.gov Identifier

  NCT02201381

• Duration of Study in the UK

  6 years, 0 months, 1 days

• Research summary

  A study designed to determine the safety and the effectiveness of a regime of selected four metabolic treatments used to treat all types of cancers in a real world setting (cancer clinic). The study will measure the overall survival, changes in tumour size, if the tumour spreads and the increase or decrease in the overall number of tumours and/or blood cancer markers, compared against appropriate historical controls.

• REC name

  East Midlands - Leicester South Research Ethics Committee

• REC reference

  17/EM/0118

• Date of REC Opinion

  19 May 2017

• REC opinion

  Further Information Favourable Opinion